nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—chronic obstructive pulmonary disease	0.302	1	CbGaD
Bezafibrate—Ritodrine—Arformoterol—chronic obstructive pulmonary disease	0.221	0.5	CrCrCtD
Bezafibrate—Ritodrine—Formoterol—chronic obstructive pulmonary disease	0.221	0.5	CrCrCtD
Bezafibrate—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0324	0.285	CbGbCtD
Bezafibrate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0229	0.201	CbGbCtD
Bezafibrate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0155	0.136	CbGbCtD
Bezafibrate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0148	0.13	CbGbCtD
Bezafibrate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0132	0.116	CbGbCtD
Bezafibrate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00772	0.0679	CbGbCtD
Bezafibrate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00729	0.0641	CbGbCtD
Bezafibrate—PPARG—leg—chronic obstructive pulmonary disease	0.00381	0.201	CbGeAlD
Bezafibrate—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.002	0.0301	CcSEcCtD
Bezafibrate—PPARA—connective tissue—chronic obstructive pulmonary disease	0.00151	0.0798	CbGeAlD
Bezafibrate—PPARA—smooth muscle tissue—chronic obstructive pulmonary disease	0.00139	0.073	CbGeAlD
Bezafibrate—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.0192	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0184	CcSEcCtD
Bezafibrate—HMGCR—respiratory system—chronic obstructive pulmonary disease	0.00115	0.0603	CbGeAlD
Bezafibrate—PPARD—lung—chronic obstructive pulmonary disease	0.00107	0.0565	CbGeAlD
Bezafibrate—Gastritis—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.0157	CcSEcCtD
Bezafibrate—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0153	CcSEcCtD
Bezafibrate—HMGCR—connective tissue—chronic obstructive pulmonary disease	0.00101	0.0531	CbGeAlD
Bezafibrate—PPARG—respiratory system—chronic obstructive pulmonary disease	0.000946	0.0498	CbGeAlD
Bezafibrate—HMGCR—bronchus—chronic obstructive pulmonary disease	0.000942	0.0496	CbGeAlD
Bezafibrate—HMGCR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000922	0.0486	CbGeAlD
Bezafibrate—PPARA—lung—chronic obstructive pulmonary disease	0.000914	0.0481	CbGeAlD
Bezafibrate—HMGCR—trachea—chronic obstructive pulmonary disease	0.000846	0.0446	CbGeAlD
Bezafibrate—PPARG—connective tissue—chronic obstructive pulmonary disease	0.000833	0.0439	CbGeAlD
Bezafibrate—PPARG—smooth muscle tissue—chronic obstructive pulmonary disease	0.000762	0.0401	CbGeAlD
Bezafibrate—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000681	0.0102	CcSEcCtD
Bezafibrate—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00065	0.00979	CcSEcCtD
Bezafibrate—Ritodrine—ADRB2—chronic obstructive pulmonary disease	0.000644	0.248	CrCbGaD
Bezafibrate—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00944	CcSEcCtD
Bezafibrate—HMGCR—lung—chronic obstructive pulmonary disease	0.000608	0.032	CbGeAlD
Bezafibrate—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00907	CcSEcCtD
Bezafibrate—Indomethacin—CXCL8—chronic obstructive pulmonary disease	0.000593	0.228	CrCbGaD
Bezafibrate—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000576	0.0303	CbGeAlD
Bezafibrate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000574	0.00864	CcSEcCtD
Bezafibrate—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00835	CcSEcCtD
Bezafibrate—Moclobemide—CYP1A2—chronic obstructive pulmonary disease	0.000553	0.213	CrCbGaD
Bezafibrate—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00809	CcSEcCtD
Bezafibrate—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00809	CcSEcCtD
Bezafibrate—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.000528	0.00795	CcSEcCtD
Bezafibrate—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.000528	0.00795	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000526	0.00793	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00792	CcSEcCtD
Bezafibrate—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00792	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000526	0.00792	CcSEcCtD
Bezafibrate—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000523	0.00787	CcSEcCtD
Bezafibrate—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00776	CcSEcCtD
Bezafibrate—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00776	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000515	0.00776	CcSEcCtD
Bezafibrate—Clofibrate—CYP1A1—chronic obstructive pulmonary disease	0.000511	0.197	CrCbGaD
Bezafibrate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000509	0.00766	CcSEcCtD
Bezafibrate—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00764	CcSEcCtD
Bezafibrate—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00764	CcSEcCtD
Bezafibrate—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000505	0.0076	CcSEcCtD
Bezafibrate—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.0076	CcSEcCtD
Bezafibrate—PPARG—lung—chronic obstructive pulmonary disease	0.000502	0.0265	CbGeAlD
Bezafibrate—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000501	0.00755	CcSEcCtD
Bezafibrate—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000496	0.00747	CcSEcCtD
Bezafibrate—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.00747	CcSEcCtD
Bezafibrate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000494	0.00744	CcSEcCtD
Bezafibrate—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00733	CcSEcCtD
Bezafibrate—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000486	0.00731	CcSEcCtD
Bezafibrate—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000479	0.00722	CcSEcCtD
Bezafibrate—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000474	0.025	CbGeAlD
Bezafibrate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000472	0.00711	CcSEcCtD
Bezafibrate—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00705	CcSEcCtD
Bezafibrate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000459	0.00691	CcSEcCtD
Bezafibrate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000457	0.00688	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00682	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00682	CcSEcCtD
Bezafibrate—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00679	CcSEcCtD
Bezafibrate—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00679	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00672	CcSEcCtD
Bezafibrate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.00641	CcSEcCtD
Bezafibrate—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000425	0.0224	CbGeAlD
Bezafibrate—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00617	CcSEcCtD
Bezafibrate—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00617	CcSEcCtD
Bezafibrate—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00614	CcSEcCtD
Bezafibrate—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00614	CcSEcCtD
Bezafibrate—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00609	CcSEcCtD
Bezafibrate—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00609	CcSEcCtD
Bezafibrate—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00604	CcSEcCtD
Bezafibrate—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00601	CcSEcCtD
Bezafibrate—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00597	CcSEcCtD
Bezafibrate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000395	0.00595	CcSEcCtD
Bezafibrate—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00582	CcSEcCtD
Bezafibrate—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.0058	CcSEcCtD
Bezafibrate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000383	0.00576	CcSEcCtD
Bezafibrate—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00576	CcSEcCtD
Bezafibrate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000382	0.00575	CcSEcCtD
Bezafibrate—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00575	CcSEcCtD
Bezafibrate—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00571	CcSEcCtD
Bezafibrate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000364	0.00549	CcSEcCtD
Bezafibrate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000364	0.00548	CcSEcCtD
Bezafibrate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000362	0.00545	CcSEcCtD
Bezafibrate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00544	CcSEcCtD
Bezafibrate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.00525	CcSEcCtD
Bezafibrate—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000345	0.0052	CcSEcCtD
Bezafibrate—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.0052	CcSEcCtD
Bezafibrate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000343	0.00517	CcSEcCtD
Bezafibrate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00511	CcSEcCtD
Bezafibrate—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00509	CcSEcCtD
Bezafibrate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00503	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000331	0.00498	CcSEcCtD
Bezafibrate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00495	CcSEcCtD
Bezafibrate—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00491	CcSEcCtD
Bezafibrate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00482	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00474	CcSEcCtD
Bezafibrate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.00468	CcSEcCtD
Bezafibrate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00461	CcSEcCtD
Bezafibrate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00461	CcSEcCtD
Bezafibrate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00461	CcSEcCtD
Bezafibrate—CYP1A1—lung—chronic obstructive pulmonary disease	0.000306	0.0161	CbGeAlD
Bezafibrate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.00459	CcSEcCtD
Bezafibrate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00451	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00447	CcSEcCtD
Bezafibrate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000291	0.00439	CcSEcCtD
Bezafibrate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000291	0.00439	CcSEcCtD
Bezafibrate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00435	CcSEcCtD
Bezafibrate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00435	CcSEcCtD
Bezafibrate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00432	CcSEcCtD
Bezafibrate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000285	0.0043	CcSEcCtD
Bezafibrate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.00429	CcSEcCtD
Bezafibrate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00427	CcSEcCtD
Bezafibrate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00423	CcSEcCtD
Bezafibrate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00414	CcSEcCtD
Bezafibrate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.0041	CcSEcCtD
Bezafibrate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00403	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00402	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00402	CcSEcCtD
Bezafibrate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00399	CcSEcCtD
Bezafibrate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00399	CcSEcCtD
Bezafibrate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00397	CcSEcCtD
Bezafibrate—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00395	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00394	CcSEcCtD
Bezafibrate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00391	CcSEcCtD
Bezafibrate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00389	CcSEcCtD
Bezafibrate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00389	CcSEcCtD
Bezafibrate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00387	CcSEcCtD
Bezafibrate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.00384	CcSEcCtD
Bezafibrate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00381	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.0038	CcSEcCtD
Bezafibrate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00378	CcSEcCtD
Bezafibrate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00378	CcSEcCtD
Bezafibrate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00378	CcSEcCtD
Bezafibrate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00378	CcSEcCtD
Bezafibrate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00377	CcSEcCtD
Bezafibrate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000246	0.0037	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.0037	CcSEcCtD
Bezafibrate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.00368	CcSEcCtD
Bezafibrate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00367	CcSEcCtD
Bezafibrate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00367	CcSEcCtD
Bezafibrate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00366	CcSEcCtD
Bezafibrate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00365	CcSEcCtD
Bezafibrate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00363	CcSEcCtD
Bezafibrate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00362	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00361	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00361	CcSEcCtD
Bezafibrate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00357	CcSEcCtD
Bezafibrate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00357	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00354	CcSEcCtD
Bezafibrate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00351	CcSEcCtD
Bezafibrate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00351	CcSEcCtD
Bezafibrate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00349	CcSEcCtD
Bezafibrate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00349	CcSEcCtD
Bezafibrate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00345	CcSEcCtD
Bezafibrate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00345	CcSEcCtD
Bezafibrate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.00345	CcSEcCtD
Bezafibrate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00344	CcSEcCtD
Bezafibrate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00343	CcSEcCtD
Bezafibrate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00342	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00341	CcSEcCtD
Bezafibrate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00331	CcSEcCtD
Bezafibrate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.0033	CcSEcCtD
Bezafibrate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00325	CcSEcCtD
Bezafibrate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00325	CcSEcCtD
Bezafibrate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.00325	CcSEcCtD
Bezafibrate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00319	CcSEcCtD
Bezafibrate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00312	CcSEcCtD
Bezafibrate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00312	CcSEcCtD
Bezafibrate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00312	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00312	CcSEcCtD
Bezafibrate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00307	CcSEcCtD
Bezafibrate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00306	CcSEcCtD
Bezafibrate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00302	CcSEcCtD
Bezafibrate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00302	CcSEcCtD
Bezafibrate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00296	CcSEcCtD
Bezafibrate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00295	CcSEcCtD
Bezafibrate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00293	CcSEcCtD
Bezafibrate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00292	CcSEcCtD
Bezafibrate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00292	CcSEcCtD
Bezafibrate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00286	CcSEcCtD
Bezafibrate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00285	CcSEcCtD
Bezafibrate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00281	CcSEcCtD
Bezafibrate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00278	CcSEcCtD
Bezafibrate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00278	CcSEcCtD
Bezafibrate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00278	CcSEcCtD
Bezafibrate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00278	CcSEcCtD
Bezafibrate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00277	CcSEcCtD
Bezafibrate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00277	CcSEcCtD
Bezafibrate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00276	CcSEcCtD
Bezafibrate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00273	CcSEcCtD
Bezafibrate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00272	CcSEcCtD
Bezafibrate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00271	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00269	CcSEcCtD
Bezafibrate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00267	CcSEcCtD
Bezafibrate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00263	CcSEcCtD
Bezafibrate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00263	CcSEcCtD
Bezafibrate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00262	CcSEcCtD
Bezafibrate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00262	CcSEcCtD
Bezafibrate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00261	CcSEcCtD
Bezafibrate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00257	CcSEcCtD
Bezafibrate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00248	CcSEcCtD
Bezafibrate—Indomethacin—ALB—chronic obstructive pulmonary disease	0.000154	0.0594	CrCbGaD
Bezafibrate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00216	CcSEcCtD
Bezafibrate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00216	CcSEcCtD
Bezafibrate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00213	CcSEcCtD
Bezafibrate—Glyburide—ALB—chronic obstructive pulmonary disease	0.000139	0.0536	CrCbGaD
Bezafibrate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00204	CcSEcCtD
Bezafibrate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00197	CcSEcCtD
Bezafibrate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.0019	CcSEcCtD
Bezafibrate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00181	CcSEcCtD
Bezafibrate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00176	CcSEcCtD
Bezafibrate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00173	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00158	CcSEcCtD
Bezafibrate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00158	CcSEcCtD
Bezafibrate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00157	CcSEcCtD
Bezafibrate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00153	CcSEcCtD
Bezafibrate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00151	CcSEcCtD
Bezafibrate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.00151	CcSEcCtD
Bezafibrate—Headache—Prednisolone—chronic obstructive pulmonary disease	9.95e-05	0.0015	CcSEcCtD
Bezafibrate—Constipation—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.00149	CcSEcCtD
Bezafibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.84e-05	0.00183	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.84e-05	0.00183	CbGpPWpGaD
Bezafibrate—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.71e-05	0.0018	CbGpPWpGaD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	9.66e-05	0.0018	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.00142	CcSEcCtD
Bezafibrate—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.43e-05	0.00142	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	9.33e-05	0.00173	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	9.22e-05	0.00171	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—chronic obstructive pulmonary disease	9.22e-05	0.00171	CbGpPWpGaD
Bezafibrate—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.00138	CcSEcCtD
Bezafibrate—PPARD—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.14e-05	0.0017	CbGpPWpGaD
Bezafibrate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.00137	CcSEcCtD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.06e-05	0.00168	CbGpPWpGaD
Bezafibrate—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	9.03e-05	0.00168	CbGpPWpGaD
Bezafibrate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	8.99e-05	0.00167	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	8.91e-05	0.00166	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GC—chronic obstructive pulmonary disease	8.89e-05	0.00165	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.61e-05	0.0016	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.58e-05	0.0016	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00128	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.4e-05	0.00156	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.26e-05	0.00154	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.19e-05	0.00152	CbGpPWpGaD
Bezafibrate—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.00123	CcSEcCtD
Bezafibrate—PPARG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	7.98e-05	0.00148	CbGpPWpGaD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.97e-05	0.00148	CbGpPWpGaD
Bezafibrate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.00119	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	7.85e-05	0.00146	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	7.85e-05	0.00146	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—TNF—chronic obstructive pulmonary disease	7.72e-05	0.00143	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	7.66e-05	0.00142	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.65e-05	0.00142	CbGpPWpGaD
Bezafibrate—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.00115	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.61e-05	0.00141	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.56e-05	0.00141	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.55e-05	0.0014	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APIP—chronic obstructive pulmonary disease	7.53e-05	0.0014	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.49e-05	0.00139	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.43e-05	0.00138	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.43e-05	0.00138	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GC—chronic obstructive pulmonary disease	7.4e-05	0.00138	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.34e-05	0.00136	CbGpPWpGaD
Bezafibrate—Rash—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.0011	CcSEcCtD
Bezafibrate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.00109	CcSEcCtD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.27e-05	0.00135	CbGpPWpGaD
Bezafibrate—Headache—Prednisone—chronic obstructive pulmonary disease	7.23e-05	0.00109	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	7.17e-05	0.00133	CbGpPWpGaD
Bezafibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.17e-05	0.00133	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	7.15e-05	0.00133	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	7.03e-05	0.00131	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.02e-05	0.0013	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.96e-05	0.00129	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.95e-05	0.00129	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.93e-05	0.00129	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.9e-05	0.00128	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.88e-05	0.00128	CbGpPWpGaD
Bezafibrate—Nausea—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.00103	CcSEcCtD
Bezafibrate—PPARA—Metabolism—GC—chronic obstructive pulmonary disease	6.77e-05	0.00126	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	6.68e-05	0.00124	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.68e-05	0.00124	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	6.66e-05	0.00124	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.58e-05	0.00122	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	6.56e-05	0.00122	CbGpPWpGaD
Bezafibrate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.53e-05	0.00121	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	6.39e-05	0.00119	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.36e-05	0.00118	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.3e-05	0.00117	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.27e-05	0.00117	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.22e-05	0.00116	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	5.93e-05	0.0011	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.89e-05	0.0011	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.83e-05	0.00108	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.75e-05	0.00107	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.71e-05	0.00106	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.63e-05	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.63e-05	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	5.62e-05	0.00105	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.61e-05	0.00104	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.59e-05	0.00104	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.59e-05	0.00104	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.48e-05	0.00102	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.4e-05	0.001	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.38e-05	0.001	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.37e-05	0.000998	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.33e-05	0.000991	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.33e-05	0.00099	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.33e-05	0.00099	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.3e-05	0.000986	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	5.29e-05	0.000984	CbGpPWpGaD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.28e-05	0.000981	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.25e-05	0.000976	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.23e-05	0.000972	CbGpPWpGaD
Bezafibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.21e-05	0.000969	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	5.04e-05	0.000936	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.02e-05	0.000932	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.99e-05	0.000927	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.95e-05	0.00092	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.93e-05	0.000917	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.87e-05	0.000906	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.87e-05	0.000906	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.86e-05	0.000904	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.86e-05	0.000903	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GC—chronic obstructive pulmonary disease	4.85e-05	0.000902	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.81e-05	0.000894	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GCLC—chronic obstructive pulmonary disease	4.8e-05	0.000892	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.8e-05	0.000891	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	4.7e-05	0.000874	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.51e-05	0.000839	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.48e-05	0.000832	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.47e-05	0.000831	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.41e-05	0.000819	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CTGF—chronic obstructive pulmonary disease	4.38e-05	0.000814	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.29e-05	0.000798	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.28e-05	0.000796	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.24e-05	0.000787	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.23e-05	0.000786	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.18e-05	0.000777	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.08e-05	0.000759	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.06e-05	0.000755	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.05e-05	0.000752	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.04e-05	0.00075	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4e-05	0.000743	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GCLC—chronic obstructive pulmonary disease	4e-05	0.000743	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.93e-05	0.00073	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.9e-05	0.000724	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.82e-05	0.00071	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	3.79e-05	0.000705	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.77e-05	0.0007	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.74e-05	0.000694	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.73e-05	0.000693	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.72e-05	0.000692	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.72e-05	0.000691	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.7e-05	0.000688	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GCLC—chronic obstructive pulmonary disease	3.66e-05	0.00068	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CTGF—chronic obstructive pulmonary disease	3.65e-05	0.000678	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.6e-05	0.000669	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.000668	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.55e-05	0.00066	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.49e-05	0.000649	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.41e-05	0.000634	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.41e-05	0.000633	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.37e-05	0.000626	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.36e-05	0.000625	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CTGF—chronic obstructive pulmonary disease	3.34e-05	0.00062	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.32e-05	0.000617	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.24e-05	0.000603	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.000582	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.09e-05	0.000575	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.09e-05	0.000574	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.08e-05	0.000572	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000572	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.05e-05	0.000566	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.93e-05	0.000545	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.93e-05	0.000545	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.93e-05	0.000544	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.91e-05	0.000541	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.87e-05	0.000533	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.000526	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.8e-05	0.000521	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.77e-05	0.000514	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.68e-05	0.000498	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.65e-05	0.000493	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.65e-05	0.000493	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.63e-05	0.000489	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	2.62e-05	0.000487	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.61e-05	0.000485	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.58e-05	0.000479	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.57e-05	0.000478	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.57e-05	0.000477	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.56e-05	0.000477	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.53e-05	0.00047	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.46e-05	0.000458	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.44e-05	0.000454	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.44e-05	0.000454	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.44e-05	0.000454	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000452	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.41e-05	0.000449	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000446	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.4e-05	0.000445	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.000445	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.37e-05	0.00044	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.37e-05	0.00044	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.36e-05	0.000438	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.000423	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.26e-05	0.00042	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.25e-05	0.000419	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.24e-05	0.000417	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000416	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000415	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000414	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.00041	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.2e-05	0.000408	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.1e-05	0.00039	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.09e-05	0.000388	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.06e-05	0.000384	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000379	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—chronic obstructive pulmonary disease	1.99e-05	0.00037	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.96e-05	0.000364	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000358	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.000354	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.89e-05	0.00035	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.00035	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000342	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.83e-05	0.00034	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.83e-05	0.00034	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.82e-05	0.000338	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.000337	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.74e-05	0.000323	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.73e-05	0.000322	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.7e-05	0.000315	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	0.000314	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—chronic obstructive pulmonary disease	1.66e-05	0.000309	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000302	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.62e-05	0.0003	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000298	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000295	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—chronic obstructive pulmonary disease	1.52e-05	0.000282	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.45e-05	0.00027	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.45e-05	0.000269	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.43e-05	0.000265	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000261	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.000247	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.000243	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000242	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.29e-05	0.00024	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000234	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.21e-05	0.000225	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000224	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000223	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.00022	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.18e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000206	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.1e-05	0.000204	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000202	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000202	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000201	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000193	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.97e-06	0.000185	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.07e-06	0.000169	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.95e-06	0.000166	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	8.57e-06	0.000159	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.34e-06	0.000155	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.32e-06	0.000155	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.2e-06	0.000152	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.2e-06	0.000152	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.64e-06	0.000142	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.24e-06	0.000135	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.44e-06	0.00012	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.37e-06	0.000118	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.81e-06	0.000108	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.37e-06	9.98e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.35e-06	9.95e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.14e-06	9.55e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.92e-06	9.15e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.71e-06	8.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.46e-06	8.3e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.4e-06	8.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.1e-06	7.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.89e-06	7.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.64e-06	4.91e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.53e-06	4.7e-05	CbGpPWpGaD
